PGT-A
Right Embryo
Unique innovation to improve the odds of pregnancy and IVF success
PGT-A
Right Embryo
Unique innovation to improve the odds of pregnancy and IVF success
The only test using artificial intelligence (AI) based on clinical outcome data, eliminating subjectivity, and improving accuracy.
Using two independent analyses (CNV & SNP) to check for abnormalities, providing greater confidence in robust and accurate results.
Key Product Information
Introducing PGT-A with PTA
We are implementing Primary Template-directed Amplification (PTA), a novel approach to DNA amplification for embryo biopsy samples.
This innovation represents the first major advancement to DNA amplification since 2009 and marks a milestone in improving the quality of DNA amplification in embryo samples.
This change is being implemented because CooperSurgical Genomics, hopes to provide the most advanced technology available to you and your patients which means from time-to-time upgrades to our technology require that we permanently discontinue outdated processes.
If you have any queries or would like any further information please click here to contact your Territory Account Manager or Clinical Support Specialist.
Laboratory Process Improvement Timeline
Don’t forget to mark your calendar with these important dates
Excluding New York State samples and samples sent to our UK-based laboratory
Clinic Testimonials
At CARE Fertility, we have been impressed with the transition from standard to PGTai; the staff education and clarity of reporting. In addition, we are reassured by the increased precision of this test and believe it brings benefits for our patients.
Alison Campbell
Director of Embryology, CARE Fertility Group, London, UK
The switch to PGTai has more than halved the turnaround time on our results, with the lab now averaging 3 days from sample receipt to providing us with the final report. That’s been an enormous benefit, those extra few days waiting for results make a huge difference to our patients! We’ve seen a drop in the number of ‘no call’ results since the changeover to below 2%. Most importantly the level of service from the staff we deal with in the UK laboratory has been outstanding, always friendly, helpful and on top of anything we need.
Kelli Sorby
Scientific Director, Number1 Fertility, Melbourne, Australia
Documents
Reproductive Genetic Testing Brochure – Czech
Reproductive Genetic Testing Brochure – Finnish
Reproductive Genetic Testing Brochure – French
Reproductive Genetic Testing Brochure – German
Reproductive Genetic Testing Brochure – Greek
Reproductive Genetic Testing Brochure – Italian
Reproductive Genetic Testing Brochure – Latvian
Reproductive Genetic Testing Brochure – Spanish(LATAM)
Reproductive Genetic Testing Brochure – Spanish
Reproductive Genetic Testing Brochure – Turkish
PGT-A Clinician Brochure – Czech
PGT-A Clinician Brochure – French
PGT-A Clinician Brochure – Greek
PGT-A Clinician Brochure – Italian
PGT-A Clinician Brochure – Portuguese
PGT-A Clinician Brochure – Spanish
PGT-A Clinician Brochure – Spanish LATAM
PGT-A Clinician Brochure – Thai
PGT-A Clinician Brochure – Turkish
PGT-A Patient Brochure – Arabic
PGT-A Patient Brochure – Czech
PGT-A Patient Brochure – French
PGT-A Patient Brochure – Greek
PGT-A Patient Brochure – Italian
PGT-A Patient Brochure – Portuguese
PGT-A Patient Brochure – Spanish
PGT-A Patient Brochure – Spanish LATAM
PGT-A Patient Brochure – Thai
PGT-A Patient Brochure – Turkish